Carmen Domínguez-Alonso

7PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 27, 2025
Simultaneous secretion of a PD-L1 x 4-1BB bispecific antibody improves antileukemic efficacy of STAb-T cells secreting a CD19-specific T-cell engager.

Marina Gómez-Rosel, Laura Rubio-Pérez, Ivana Zagorac

|Aug 29, 2024
CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts.

Anaïs Jiménez-Reinoso, Magdalena Molero-Abraham, Cristina Cirauqui

|Feb 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas

|Apr 28, 2023
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response.

Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean L Harwood

|Apr 01, 2022
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.

Belén Blanco, Ángel Ramírez-Fernández, Clara Bueno

|Jun 10, 2021
Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy.

Belén Blanco, Carmen Domínguez-Alonso, Luis Alvarez-Vallina

Pageof 2

Frequent Collaborators

7 joint publications

Belén Blanco

7 joint publications

Luis Alvarez-Vallina

4 joint publications

Marta Compte

4 joint publications

Laura Rubio-Pérez